Seattle, WA, United States of America

Claire L Sutherland

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 10.3

ph-index = 2

Forward Citations = 12(Granted Patents)


Company Filing History:


Years Active: 2022-2024

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Claire L. Sutherland: Innovator in Cell Therapy

Introduction

Claire L. Sutherland is a prominent inventor based in Seattle, WA (US). She has made significant contributions to the field of cell therapy, particularly in the development of methods and compositions that enhance the safety and efficacy of therapeutic T cell compositions. With a total of 4 patents, her work is paving the way for advancements in cancer treatment.

Latest Patents

One of her latest patents focuses on "Determining toxicity risk in CAR T-cell therapy." This patent provides methods, compositions, and articles of manufacture for use in cell therapy involving the administration of therapeutic T cell compositions. The T cell compositions express recombinant receptors, such as chimeric antigen receptors (CARs) or other transgenic receptors. The features of this patent offer various advantages, including a lower risk of toxicity in subjects receiving the T cell compositions.

Another significant patent by Claire is titled "Phenotypic markers for cell therapy and related methods." This invention also involves methods, compositions, and articles of manufacture for therapeutic T cell compositions. The innovations presented in this patent aim to ensure consistent dosing and lower toxicity risks, ultimately increasing the response rates in subjects administered the T cell compositions.

Career Highlights

Claire L. Sutherland is currently associated with Juno Therapeutics GmbH, where she continues to advance her research in cell therapy. Her work is instrumental in developing safer and more effective treatments for patients.

Collaborations

Some of her notable coworkers include Christopher Glen Ramsborg and Brian Christin, who collaborate with her on various projects within the field of cell therapy.

Conclusion

Claire L. Sutherland is a trailblazer in the realm of cell therapy, with her innovative patents contributing to safer treatment options for patients. Her dedication to research and collaboration with esteemed colleagues underscores her commitment to advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…